Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 265

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 265
---
 of its officers. Subject to providing continuous service to the Company, the RSUs all fully vest on June 1, 2024. The RSUs were valued using the closing price of the Company’s common stock on the date of issuance with the total expense of $ 186 being recognized over the vesting period of one year .

As of June 30, 2024, 4 RSU had vested and were converted to common shares, and 60 RSU had vested but were converted to common shares subsequent to June 30, 2024.

<div align='center'>F-2 4</div>

During the year ended June 30, 2024, the Company recognized a total of $ 171 (2023 - $ 90 ) related to RSU.

| Balance – June 30, 2022               |     | Number ofRSU(in thousands) |  — |   |
|:--------------------------------------|:----|:---------------------------|---:|:--|
| Issuance                              |     |                            | 78 |   |
| Balance – June 30, 2023               |     |                            | 78 |   |
| Vested and converted to common shares |     |                            | (4 | ) |
| Forfeited                             |     |                            | (8 | ) |
| Balance – June 30, 2024               |     |                            | 66 |   |

Common stock warrants

The following table sets forth changes in outstanding warrants:

| Balance – June 30, 2022                    
 Expiry of 2018 Investor and Agent warrants |     | Number ofwarrants(in thousands) | 720 
  (7 | ) |     | Weightedaverageexerciseprice$ |  49.36 
 625.68 |
|:-------------------------------------------|:----|:--------------------------------|----:|:--|:----|:------------------------------|-------:|
| Balance – June 30, 2023                    |     |                                 | 713 |   |     |                               |  43.55 |
| Expiry of warrants issued for services     |     |                                 | (20 | ) |     |                               |  71.53 |
| Expiry of 2019 Investor and Agent warrants |     |                                 | (16 | ) |     |                               | 157.25 |
| Balance – June 30, 2024                    |     |                                 | 677 |   |     |                               |